Skip to main content

Table 2 Types of DRPs and PIs

From: Clinical, economic and organizational impact of pharmacist interventions on injectable antineoplastic prescriptions: a prospective observational study

Drug related problems

n (%)

Supratherapeutic dosage

98 (41.4)

Subtherapeutic dosage

36 (15.2)

Drug monitoring

29 (12.2)

Non-conformity to guidelines

26 (11.0)

Untreated indication

23 (9.7)

Inappropriate timing of administration

9 (3.8)

Drug without indication

7 (3.0)

Contra-indication

4 (1.7)

Improper administration

2 (0.8)

Adverse drug reaction

1 (0.4)

Non-conformity of the drug choice compared to the Formulary

1 (0.4)

Treatment not received

1 (0.4)

Interventions

 Dose adjustment

125 (52.7)

 Drug switch

36 (15.2)

 Addition of a new drug

23 (9.7)

 Drug monitoring

22 (9.3)

 Drug discontinuation

19 (8.0)

 Administration mode optimization

12 (5.1)

Total

237 (100)